2019
DOI: 10.1016/j.jnutbio.2019.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Quercetin and its derivative Q2 modulate chromatin dynamics in adipogenesis and Q2 prevents obesity and metabolic disorders in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
29
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 46 publications
(30 citation statements)
references
References 75 publications
1
29
0
Order By: Relevance
“…The expression of CB2-Rs in the central nervous system is increased in neurodegenerative pathologies, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS) and in some tumours like gliomas [14]. In addition to the involvement in physiological functions, CB2-Rs are implied in numerous pathological processes, so they can represent an interesting target in order to obtain agonist molecules for the treatment of many pathological conditions, including neuropathic pain, inflammation, neuroinflammatory and neurodegenerative pathologies (Parkinson's disease, Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis), spinal and brain injuries, stroke, ischemia, anxiety disorder, depression, colitis, fibrosis and liver ischemia, atherosclerosis, osteoporosis, osteoarthritis, diabetes, obesity, and some types of cancer [9,[12][13][14][16][17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…The expression of CB2-Rs in the central nervous system is increased in neurodegenerative pathologies, such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS) and in some tumours like gliomas [14]. In addition to the involvement in physiological functions, CB2-Rs are implied in numerous pathological processes, so they can represent an interesting target in order to obtain agonist molecules for the treatment of many pathological conditions, including neuropathic pain, inflammation, neuroinflammatory and neurodegenerative pathologies (Parkinson's disease, Alzheimer's disease, multiple sclerosis, and amyotrophic lateral sclerosis), spinal and brain injuries, stroke, ischemia, anxiety disorder, depression, colitis, fibrosis and liver ischemia, atherosclerosis, osteoporosis, osteoarthritis, diabetes, obesity, and some types of cancer [9,[12][13][14][16][17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…To date, a special attention for both prophylactic and therapeutic interventions in T2D is directed to diet nutrients, able to regulate the metabolism and in uence the consumer's health 47 . Quercetin is a nutraceutical compound with anti-in ammatory and antioxidant effects both in vivo and in vitro.…”
Section: Discussionmentioning
confidence: 99%
“…Quercetin is a nutraceutical compound with anti-in ammatory and antioxidant effects both in vivo and in vitro. Possible mechanisms of actions include inhibition of COX-2, NF-kB and MAPK pathways, post-translational modi cations and elimination of senescent cells [47][48][49] . Here, we have shown that quercetin ameliorates the local low-grade in ammation by reducing the expression of TNF-α and the release of a number of in ammatory cytokines in MSCs isolated from IGT and T2D morbid obese subjects.…”
Section: Discussionmentioning
confidence: 99%
“…Among these derivatives, Q2 and Q5 have better bioavailability and stability than other derivatives. It was found that Q2 has a better anti-obesity effect and remission on metabolic disorders with respect to Que ( Nettore et al, 2019 ). The evaluation of the bioavailability of Q5 has reached 19% at the end of the experiment compared to Que (11%) in vitro .…”
Section: Protective Effects Against Calcium Overloadmentioning
confidence: 99%